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Purpose or Objective: Consistency of bladder volume (BV) 
during radiotherapy (RT) planning and treatment is important 
in maintaining the position of the prostate and the 
surrounding organs at risk, thus minimising RT-related tissue 
toxicity. This retrospective study evaluated the effectiveness 
of bladder-filling instructions in achieving a consistent and 
reproducible bladder volume at the time of planning CT and 
during the course of radical RT for prostate cancer. This 
study also assessed the rate of bladder filling (inflow) during 
the course of RT. 
 
Material and Methods: 28 men with localized prostate cancer 
were instructed to void their bladder and then drink 500 ml 
of water before proceeding to RT planning scan 45 minutes 
later. This bladder filling process was repeated daily before 
each RT session. BV was assessed during planning CT and at 
four chronological phases of RT (fractions 1-9, 10-19, 20-29 
and 30-37) via cone beam CT (CBCT). Each patient had 
between four to ten CBCTs taken during his RT sessions and 
the average BV at each phase was calculated. Inflow was 
assessed using delineated BV post-treatment in 20 patients. 
Inflow was calculated by taking the difference in BV between 
pre-RT CBCT and post-RT CBCT and dividing by the time 
between the scans. All patients were treated with 74 Gy in 
37 fractions via intensity modulated radiotherapy (IMRT). 
 
Results: The mean BV for all treatments (mean= 223.62 ml, 
range= 57.18– 871.85 ml, SD= 138.08 ml) was significantly 
lower (p=0.007) than the mean BV at the time of planning 
(mean= 318.88ml, range= 93.96 – 821.37 ml, SD= 165.10 ml). 
During RT, 68%, 50% and 38% of pre-treatment BV had >50ml, 
>100ml and >150 ml difference respectively when compared 
with their volume at the time of planning. When assessing 
the BV at different treatment time points, the mean BV for 
RT fractions 1-9 (239.31ml) was 25% lower than the mean 
planning volume (p= 0.025). The mean BV for RT sessions 30-
37 (203.65 ml) was 36% lower than the mean planning volume 
(p<0.001).  
Inflow over 128 fractions was significantly correlated 
(r=0.558, p<0.0001) with pre-RT BV. The mean inflow did not 
differ significantly over the course of RT. The mean inflow of 
RT sessions 1-9 (3.86 ml/min, SD= 2.50 ml/min) was not 
significantly higher (p=0.24) than that of RT sessions 30-37 
(3.29 ml/min, SD=2.46 ml/min). 
 
 
 
 
 
Conclusion: A difference in BV was found between planning 
and during the course of radiotherapy. The mean BV 
decreased most during the first two weeks of radiotherapy. 
The large decrease in BV at the early phase of RT suggests a 
systematic difference in bladder filling at the time of 
planning compared with treatment. This process has been 
reviewed and a further analysis will be performed. Inflow 
from pre- and post-CBCT scans was found to be correlated 
with pre-RT BV. Inflow information may help to reduce 
bladder filling variations during treatment. 
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Purpose or Objective: Whole-pelvic radiotherapy (WPRT) is a 
cornerstone of the treatment of high-risk prostate cancer. 
However, late gastrointestinal (GI) toxicity is the major dose-
limiting factor in this treatment. There are concerns that 
dose escalation and aggressive treatment regimens may 
result in increased acute toxicity, which may modulate long-
term side-effects of radiotherapy, a phenomenon known as 
consequential late effects. The purpose of this work was to 
evaluate if late GI side-effects are related to acute toxicity 
using long-term patient-reported outcomes (PRO) of a 
previously unreported large, prospective phase I/II trial of 
IMRT for whole-pelvic treatment of prostate cancer. 
 
Material and Methods: 496 patients were recruited between 
August 2001 and September 2013. Treatment consisted of 
